Kush Parmar - 15 Jun 2022 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Reporting relationship: Director
Issuer ticker: QTTB
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2022, 16:05:20 UTC
Prior SEC filing: 16 Jun 2022
Next SEC filing: 27 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ W. Bradford Smith, Attorney-in-Fact for Kush Parmar

Key filing fact

Kush Parmar filed Form 4 for Homology Medicines, Inc. (QTTB) on 17 Jun 2022.

Key facts

This page summarizes Kush Parmar's Form 4 filing for Homology Medicines, Inc. (QTTB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2022, 16:05.

Change

Previous filing in this sequence was filed on 16 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FIXX transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +18,000
Change %
Price: $0.000000
Shares after: 18,000
Date: 15 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,000
Exercise price: $1.88
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option shall vest and become exercisable on the earlier of June 15, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.